Blue Shield of California does cover Zepbound for weight loss, but only if your plan includes weight-loss drugs and you meet its BMI rule. The same goes for Wegovy. Ozempic is covered for type 2 diabetes when you meet your plan’s requirements, with prior authorization, and not for weight loss.
The confusion comes from changes to Blue Shield’s coverage rules in 2025 and 2026. Individual and family plans, employer-sponsored plans, and self-funded employer plans follow different rules. A friend having coverage for a medication doesn’t mean your plan covers it, even if you both have Blue Shield cards.
TL;DR: Key Takeaways
- Individual and family plans, including Covered California: since 2025, Zepbound and Wegovy are excluded unless you have Class III obesity, a BMI of 40 or higher.
- Employer plans: since January 1, 2026, coverage depends on what your employer bought. BMI 40, BMI 30, BMI 27 with a condition, or nothing.
- Prior authorization: Blue Shield asks for your BMI records and proof of six months in a weight-management program. To renew, you need to show you’ve lost 5% of your starting weight.
- Ozempic and Mounjaro are covered for type 2 diabetes only. A high BMI doesn’t get Ozempic approved.
- Medi-Cal and Blue Shield Medicare plans don’t cover GLP-1s for weight loss; diabetes coverage continues. The $50 Medicare GLP-1 Bridge is a federal program, not a Blue Shield benefit.
Want a doctor’s answer before you dig through your plan documents? Book a $39 weight-loss visit with August AI. A board-certified MD reviews your medical history and, when clinically appropriate, sends a prescription for Wegovy, Zepbound, or Foundayo to the California pharmacy you choose. A prescription isn’t guaranteed, medication costs are separate, and August AI doesn’t prescribe compounded GLP-1s.
Does Blue Shield of California Cover Zepbound and Wegovy? It Depends on Three Things
Which Blue Shield plan is on your card decides this, and there are three kinds. Blue Shield changed the rules for weight-loss drugs in 2025 and again in 2026, so the answer you got two years ago, or the one your coworker got last month, is probably not yours.
Individual and family plans, including Covered California. If you buy your own plan, this is the strict one. Since January 1, 2025, Blue Shield covers Wegovy, Zepbound, Saxenda, Contrave, or phentermine only when it decides they’re medically necessary for Class III obesity, a BMI of 40 or higher, now or in the past. You also need a documented weight-management program, with diet, activity, and behavior therapy, before you start and while you’re on the drug. The hard part to hear: a BMI of 32 with high blood pressure qualifies you for Wegovy on the FDA label and gets you nothing here.
Fully insured employer plans. If you get Blue Shield through work, it depends on what your employer paid for. From January 1, 2026, the BMI 40 rule is the default for large group plans. Employers can add an Enhanced+ Rx rider that opens coverage at a BMI of 30, or 27 with a weight-related condition, and some chose not to cover weight-loss drugs at all. Your Summary of Benefits and Coverage says which one you have.
Self-funded employer plans. If your employer pays its own claims and Blue Shield only runs the plan, your employer wrote the rule. Ask HR, not Blue Shield.
Not sure which plan you have? Search the drug on Blue Shield’s formulary page. Zepbound shows up on the Plus and Performance formularies as a Tier 3 drug with prior authorization and a “benefit limit” flag. Listed, but your plan decides. August’s GLP-1 coverage check asks you the same questions.
Is Blue Shield the Same as Blue Cross Blue Shield?
No. Blue Shield of California and Anthem Blue Cross are separate companies with different drug lists and different GLP-1 rules. In other states, “Blue Shield” means that state’s Blue plan, and some of those have stopped covering weight-loss GLP-1s altogether; Blue Cross Blue Shield of Michigan did in January 2025. Everything on this page is Blue Shield of California only. If your card says Anthem, you’re reading the wrong article.
What Blue Shield’s Prior Authorization Asks For
Meeting your plan’s BMI rule is the first step, not the last. Your prescriber also has to show Blue Shield:
- A BMI that meets your plan’s threshold. Run yours through the BMI calculator before the visit.
- For the BMI 27 route, a weight-related condition: high blood pressure, type 2 diabetes, prediabetes, high cholesterol, heart disease, PCOS, or sleep apnea treated with CPAP.
- At least six months of a lifestyle program in the past year, with a written record.
- No other weight-loss drug or GLP-1 at the same time, and no bariatric surgery in the past 12 months.
The first approval lasts four months. To renew, you need to have lost at least 5% of your starting weight.
One more change for Zepbound users: on July 1, 2026, Blue Shield switched fully insured commercial members from single-dose pens to the multi-dose KwikPen. Existing approvals carried over, but you needed a new prescription, plus one for pen needles.
Does Blue Shield Cover Ozempic?
Yes, for type 2 diabetes. Ozempic is on every Blue Shield formulary, including individual plans, with a prior authorization that asks for a diabetes diagnosis. It isn’t covered for weight loss, and a high BMI doesn’t get it approved. Mounjaro, the diabetes version of Zepbound, follows the same rule.
One name change to know: in 2026, Novo Nordisk renamed its Rybelsus diabetes pill “Ozempic” tablets, and Blue Shield added the tablet to its Plus formulary in September with the same diabetes-only prior authorization. It’s a different drug from the Wegovy pill, which is the weight-loss tablet. Our guide to semaglutide covers the differences.
Medi-Cal and Medicare Members
Blue Shield Promise (Medi-Cal). Medi-Cal stopped covering GLP-1s for weight loss on January 1, 2026, for adults 21 and older. Coverage continues for type 2 diabetes and other FDA uses, and for members under 21. If you think you qualify under one of those, our Medi-Cal guide covers the State Hearing, which you have 90 days to request.
Blue Shield Medicare Advantage. Blue Shield’s Medicare formularies exclude weight-loss drugs. Wegovy is covered for heart-disease risk reduction with prior authorization. The Medicare GLP-1 Bridge program, July 1, 2026, through December 31, 2027, at $50 a month, is a federal program that CMS runs outside your plan. Blue Shield’s notice to doctors says the Bridge “is not a Blue Shield plan covered benefit.”
What Zepbound, Wegovy, and Ozempic Cost Without Coverage
If your plan says no, you’re paying the manufacturer’s self-pay price, about a third of the list price. Prices checked October 2026:
| Medication | Who it’s for | Self-pay price | Where |
|---|---|---|---|
| Wegovy pen | Weight loss | $349 a month at every dose; $199 for the first two fills at the two lowest doses through December 31, 2026 | NovoCare Pharmacy |
| Wegovy pill | Weight loss | $149 to $299 a month, by dose | NovoCare Pharmacy |
| Zepbound vials | Weight loss | $299 (2.5 mg), $399 (5 mg), $449 (7.5 mg and up), if you refill within 45 days | LillyDirect |
| Ozempic | Type 2 diabetes | $349 a month (0.25 to 1 mg), $499 (2 mg) | NovoCare Pharmacy |
| List price, any of them | $1,000 to $1,350 a month | Retail pharmacy, no program |
If Blue Shield does cover the drug, the manufacturer savings cards bring your copay to as low as $25 a month. They don’t work for Medicare or Medi-Cal members. Compounded GLP-1s aren’t a workaround: the FDA ended the shortage exemption in 2025, and August doesn’t prescribe them. The GLP-1 budget calculator shows a year’s cost on each option. Read does insurance cover Wegovy if you’re comparing plans at open enrollment.
If Blue Shield Denies Your Prior Authorization
Appeal. You have 180 days from the denial to file a grievance with Blue Shield. Blue Shield has 30 calendar days to decide, or 3 days if waiting puts your health at risk. If it still says no, California’s Department of Managed Health Care offers a free Independent Medical Review, where outside doctors make a decision that binds Blue Shield. Keep the denial letter: it names the criterion you missed, and that’s the one your appeal has to answer. Before you file, have your prescriber add your BMI history, the dates of your lifestyle program, and the diagnosis codes for any weight-related condition.
Conclusion
So, does Blue Shield cover Zepbound and Wegovy? For weight loss, only when your plan includes the benefit and your BMI clears its line: 40 on individual plans, and 40, 30, or 27 with a condition on employer plans. Ozempic is covered for diabetes and nothing else.
If your plan says no, you aren’t out of options. A $39 visit with August gets you a board-certified MD’s decision on whether a GLP-1 fits you. Obesity is a diagnosis, not a benefit category.
Frequently Asked Questions
Zepbound is listed for both weight management and obstructive sleep apnea, but it sits in the weight-loss benefit. If your plan excludes weight-loss drugs, ask Blue Shield in writing whether a sleep apnea diagnosis changes that. On the BMI 27 route, sleep apnea treated with CPAP counts as a qualifying condition.
On Blue Shield Medicare plans, yes, with prior authorization, because that’s an FDA use outside weight loss. On individual and employer plans, Wegovy sits on the weight-loss exclusion list whatever the diagnosis, and Blue Shield’s 2025 notice doesn’t carve out heart disease. Ask in writing before you count on it.
Only with a BMI of 40 or higher and a documented weight-loss program. Since January 2025, Blue Shield’s individual plans, including Covered California plans, exclude Wegovy below that line.
Yes, for type 2 diabetes with prior authorization, on the same terms as Ozempic. For weight loss, the same drug is sold as Zepbound, and the rules above apply. Our tirzepatide guide covers both.
